Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MiNA Therapeutics
Biotech
Former FDA deputy joins AI biotech's board—Chutes & Ladders
Former FDA deputy joins AI biotech’s board. Summit flags new CCO. Struggling Cargo jettisons assets and execs.
Darren Incorvaia
,
Zoey Becker
Mar 21, 2025 8:30am
Lilly invests in MiNA to fund trials of protein-upregulating RNA
Jul 6, 2021 8:10am
Outsmarting cancer with RNA and other gene-altering therapies
Jun 28, 2021 5:00pm
Lilly, MiNA ink broad deal to upregulate proteins using RNA
May 11, 2021 6:45am
Servier, MiNA ally to upregulate neurological disorder proteins
Jan 21, 2021 8:00am
MiNA raises $30M to take small activating RNA into phase 2
Sep 10, 2020 7:05am
